Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention. [electronic resource]
Producer: 20100617Description: 318-23 p. digitalISSN:- 1876-7605
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Biomarkers -- blood
- Blood Platelets -- drug effects
- Clopidogrel
- Coronary Artery Disease -- blood
- Creatine Kinase, MB Form -- blood
- Female
- Humans
- Logistic Models
- Male
- Middle Aged
- Myocardial Infarction -- blood
- Myocardium -- pathology
- Necrosis
- Odds Ratio
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Function Tests
- Point-of-Care Systems
- Predictive Value of Tests
- Purinergic P2 Receptor Antagonists
- Receptors, Purinergic P2 -- blood
- Receptors, Purinergic P2Y12
- Risk Assessment
- Risk Factors
- Ticlopidine -- analogs & derivatives
- Time Factors
- Treatment Outcome
- Troponin I -- blood
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.